Israel Active

Professor Nathan Karin of the Rappaport faculty of Medicine at Israel’s Technion Institute invented an antibody that activates cells in the immune system, thereby reducing inflammation. After years of development, Pfizer has now signed an agreement to commercialize the product.

Israel’s HIL Applied Medical develops safer focused proton beam lasers to treat tumors Now HIL has acquired US company Nanolabz which develops and builds smart nano-engineered targets and alignment systems for the short-pulse laser R&D sector.

Israel’s Chief Scientist has awarded NIS 5.6 million to Israel’s Collplant.  It will help finance projects, including the development of plant-based collagen and formulations intended for use as BioInk for 3D printing of tissues and organs.

International researchers and healthcare professionals attended a conference dubbed “State of the Heart.” at Haifa’s Rambam Hospital. It addressed global challenges in cardiovascular treatment and highlighted innovative changes in the field as a result of cutting-edge technology.

The Israel Chamber of Commerce hosted a special seminar titled Israeli Medical Tourism and Women Empowerment at the Israeli Business and Cultural Center in Beijing.  China is impressed with Israel’s physicians, its high-quality healthcare, and advanced medical facilities.

Israel’s NeuroRx won the startup completion at the IATI Biomed conference in Tel Aviv for its Cuclurad treatment for depression and suicide symptoms.  The popular event included some 500 Business to Business meetings between Israeli and Chinese delegates.

Tel Aviv University Professor Hayit Greenspan has developed a wide variety of “deep learning” tools to facilitate computer-assisted diagnosis of X-rays, CTs and MRIs, freeing radiologists to attend to complex cases that require their full attention and skills.

Israel’s LifeSeal, the no-leak sealant solution for patients who have undergone gastrointestinal (GI) surgery , has received CE approval for use in the European Union.  LifeSeal has also been fast-tracked for approval by the US FDA through its Expedited Access Pathway (EAP)

Social work students from Yeshiva University’s Wurzweiler School of Social Work are in Israel to attend an intensive course on trauma, emergency response and recovery.  It features workshops on trauma intervention, and real-time emergency response simulation.

Israel’s Technion and New York University’s Langone Medical Center have begun a research project, targeting metastatic melanoma and mesothelioma.  They will test the ability of a nanotechnology based on so-called “nanoghosts” using stem cells to home in on cancer cells.